NCT02446301View on ClinicalTrials.gov

A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
PainAnalgesia Disorder
Interventions
DRUG

Bain®

Nalbuphine HCl 20mg, IM injection

DRUG

SDE

Sebacoyl Dinalbuphine Ester 150mg/2ml, IM injection

Trial Locations (1)

23561

Taipei Medical University - Shuang Ho Hospital, New Taipei City

Sponsors
All Listed Sponsors
lead

Lumosa Therapeutics Co., Ltd.

INDUSTRY